Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia

por Chen, Yan, Chen, Hongmei, Birnbaum, Yochai, Nanhwan, Manjyot K, Bajaj, Mandeep, Ye, Yumei, Qian, Jinqiao
Publicado 2017